Background: P2X7 receptor has emerged as a potentially superior PET imaging marker to TSPO, the gold standard for imaging glial reactivity. [C]SMW139 is the most recently developed radiotracer to image P2X7 receptor. The aim of this study was to image reactive glia in the APP/PS1-21 transgenic (TG) mouse model of Aβ deposition longitudinally using [C]SMW139 targeting P2X7 receptor and to compare tracer uptake to that of [F]F-DPA targeting TSPO at the final imaging time point.
View Article and Find Full Text PDFThe membrane-based purinergic 7 receptor (P2XR) is expressed on activated microglia and the target of the radioligand [C]SMW139 for assessment of neuroinflammation. This study investigated the contribution of radiolabelled metabolites which potentially affect its quantification. high-performance liquid chromatography with a radio detector (radioHPLC) was used to evaluate the parent and radiometabolite fractions of [C]SMW139 in the brain and plasma of eleven mice.
View Article and Find Full Text PDFRadiometabolites of PET tracers interfere with imaging and need to be taken into account when modeling PET data. Various tracer and radiometabolite characteristics affect the uptake rate into tissue. In this study, we investigated two such factors, lipophilicity and protein-free fraction.
View Article and Find Full Text PDF